These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20646843)

  • 1. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
    Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
    Blattmann C; Oertel S; Thiemann M; Dittmar A; Roth E; Kulozik AE; Ehemann V; Weichert W; Huber PE; Stenzinger A; Debus J
    Radiat Oncol; 2015 Jul; 10():146. PubMed ID: 26178881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model.
    Blattmann C; Thiemann M; Stenzinger A; Christmann A; Roth E; Ehemann V; Debus J; Kulozik AE; Weichert W; Huber PE; Oertel S; Abdollahi A
    Strahlenther Onkol; 2013 Nov; 189(11):957-66. PubMed ID: 23801068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma.
    Ghayad SE; Rammal G; Sarkis O; Basma H; Ghamloush F; Fahs A; Karam M; Harajli M; Rabeh W; Mouawad JE; Zalzali H; Saab R
    Cancer Biol Ther; 2019; 20(3):272-283. PubMed ID: 30307360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.
    Kuribayashi T; Ohara M; Sora S; Kubota N
    Int J Mol Med; 2010 Jan; 25(1):25-9. PubMed ID: 19956898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.
    Blattmann C; Oertel S; Thiemann M; Weber KJ; Schmezer P; Zelezny O; Lopez Perez R; Kulozik AE; Debus J; Ehemann V
    Strahlenther Onkol; 2012 Feb; 188(2):168-76. PubMed ID: 22249335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
    Zhang Y; Jung M; Dritschilo A; Jung M
    Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
    Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
    J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
    Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
    Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
    Heinicke U; Fulda S
    Cancer Lett; 2014 Aug; 351(1):50-8. PubMed ID: 24814395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Deacetylase Inhibitor Induced Radiation Sensitization Effects on Human Cancer Cells after Photon and Hadron Radiation Exposure.
    Gerelchuluun A; Maeda J; Manabe E; Brents CA; Sakae T; Fujimori A; Chen DJ; Tsuboi K; Kato TA
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma.
    Lu YS; Chou CH; Tzen KY; Gao M; Cheng AL; Kulp SK; Cheng JC
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e181-9. PubMed ID: 22381897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
    Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
    J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
    Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
    Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histone deacetylase inhibits the growth and migration of human osteosarcoma cells].
    Zhang ZL; Zhang AH; Feng ZQ; An L; Zhao QH
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2680-5. PubMed ID: 24360054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
    Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.
    Konsoula Z; Cao H; Velena A; Jung M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.